Optical molecular imaging is an emerging field, and high-resolution optical imaging of the distal lung parenchyma has been made possible with the advent of clinically approved fiber-based imaging modalities. However, currently, there is no single method of allowing the simultaneous imaging and delivery of targeted molecular imaging agents. The objective of this research is to create a catheterized device capable of fulfilling this need. We describe the rationale, development, and validation in ex vivo ovine lung to near clinical readiness of a triple lumen bronchoscopy catheter that allows concurrent imaging and fluid delivery, with the aim of clinical use to deliver multiple fluorescent compounds to image alveolar pathology. Using this device, we were able to produce high-quality images of bacterial infiltrates in ex vivo ovine lung within 60 s of instilling a single microdose of (<100 mcg) imaging agent. This has many advantages for future clinical usage over the current state of the art.

References

1.
NHLBI
,
2012
, “
Disease Statistics. Factbook
,”
National Heart, Lung, and Blood Institute
,
National Institutes of Health
, Bethesda, MD.
2.
Ikeda
,
S.
,
Yanai
,
N.
, and
Ishikawa
,
S.
,
1968
, “
Flexible Bronchofiberscope
,”
Keio J. Med.
,
17
(
1
), pp.
1
16
.
3.
Andersen
,
H. A.
,
Fontana
,
R. S.
,
Harrison
,
J.
, and
Edgar
,
G.
,
1965
, “
Transbronchoscopic Lung Biopsy in Diffuse Pulmonary Disease
,”
Chest
,
48
(
2
), pp.
187
192
.
4.
Luna
,
C. M.
,
Vujacich
,
P.
,
Niederman
,
M. S.
,
Vay
,
C.
,
Gherardi
,
C.
,
Matera
,
J.
, and
Jolly
,
E. C.
,
1997
, “
Impact of BAL Data on the Therapy and Outcome of Ventilator-Associated Pneumonia
,”
Chest
,
111
(
3
), pp.
676
685
.
5.
Gereige
,
R. S.
, and
Laufer
,
P. M.
,
2013
, “
Pneumonia
,”
Pediatr. Rev.
,
34
(
10
), pp.
438
456
.
6.
Herth
,
F. J. F.
,
2011
, “
Bronchoscopic Techniques in Diagnosis and Staging of Lung Cancer
,”
Breathe
,
7
(
4
), pp.
324
337
.
7.
Meyer
,
K. C.
,
Raghu
,
G.
,
Baughman
,
R. P.
,
Brown
,
K. K.
,
Costabel
,
U.
,
duBois
,
R. M.
,
Drent
,
M.
,
Haslem
,
P. L.
,
Kim
,
D. S.
,
Nagai
,
S.
,
Rottoli
,
P.
,
Saltini
,
C.
,
Selman
,
M.
,
Strange
,
C.
, and
Wood
,
B.
,
2012
, “
An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease
,”
Am. J. Respir. Crit. Care Med.
,
185
(
9
), pp.
1004
1014
.
8.
Chastre
,
J.
, and
Fagon
,
J.-Y.
,
2002
, “
Ventilator-Associated Pneumonia
,”
Am. J. Respir. Crit. Care Med.
,
165
(
7
), pp.
867
903
.
9.
Baselski
,
V. S.
, and
Wunderink
,
R. G.
,
1994
, “
Bronchoscopic Diagnosis of Pneumonia
,”
Clin. Microbiol. Rev.
,
7
(
4
), pp.
533
558
.
10.
Johnston
,
P.
,
McAuley
,
D. F.
, and
O'Kane
,
C. M.
,
2010
, “
Novel Pulmonary Biomarkers in the Diagnosis of VAP
,”
Thorax
,
65
(
3
), pp.
190
192
.
11.
Jabbour
,
J. M.
,
Saldua
,
M. A.
,
Bixler
,
J. N.
, and
Maitland
,
K. C.
,
2011
, “
Confocal Endomicroscopy: Instrumentation and Medical Applications
,”
Ann. Biomed. Eng.
,
40
(
2
), pp.
378
397
.
12.
Thiberville
,
L.
,
Moreno-Swirc
,
S.
,
Vercauteren
,
T.
,
Peltier
,
E.
,
Cavé
,
C.
, and
Bourg Heckly
,
G.
,
2007
, “
In Vivo Imaging of the Bronchial Wall Microstructure Using Fibered Confocal Fluorescence Microscopy
,”
Am. J. Respir. Crit. Care Med.
,
175
(
1
), pp.
22
31
.
13.
Thiberville
,
L.
,
Salaün
,
M.
,
Lachkar
,
S.
,
Dominique
,
S.
,
Moreno-Swirc
,
S.
,
Vever-Bizet
,
C.
, and
Bourg-Heckly
,
G.
,
2009
, “
Human In Vivo Fluorescence Microimaging of the Alveolar Ducts and Sacs During Bronchoscopy
,”
Eur. Respir. J.
,
33
(
5
), pp.
974
985
.
14.
Salaün
,
M.
,
Roussel
,
F.
,
Hauss
,
P.-A.
,
Lachkar
,
S.
, and
Thiberville
,
L.
,
2010
, “
In Vivo Imaging of Pulmonary Alveolar Proteinosis Using Confocal Endomicroscopy
,”
Eur. Respir. J.
,
36
(
2
), pp.
451
453
.
15.
Aslam
,
T.
,
Miele
,
A.
,
Chankeshwara
,
S. V.
,
Megia-Fernandez
,
A.
,
Michels
,
C.
,
Akram
,
A. R.
,
McDonald
,
N.
,
Hirani
,
N.
,
Haslett
,
C.
,
Bradley
,
M.
, and
Dhaliwal
,
K.
,
2015
, “
Optical Molecular Imaging of Lysyl Oxidase Activity—Detection of Active Fibrogenesis in Human Lung Tissue
,”
Chem. Sci.
,
6
(
8
), pp.
4946
4953
.
16.
Avlonitis
,
N.
,
Debunne
,
M.
,
Aslam
,
T.
,
McDonald
,
N.
,
Haslett
,
C.
,
Dhaliwal
,
K.
, and
Bradley
,
M.
,
2013
, “
Highly Specific, Multi-Branched Fluorescent Reporters for Analysis of Human Neutrophil Elastase
,”
Org. Biomol. Chem.
,
11
(
26
), pp.
4414
4418
.
17.
Bunschoten
,
A.
,
Welling
,
M. M.
,
Termaat
,
M. F.
,
Sathekge
,
M.
, and
van Leeuwen
,
F. W. B.
,
2013
, “
Development and Prospects of Dedicated Tracers for the Molecular Imaging of Bacterial Infections
,”
Bioconjug. Chem.
,
24
(
12
), pp.
1971
1989
.
18.
Staderini
,
M.
,
Megia-Fernandez
,
A.
,
Dhaliwal
,
K.
, and
Bradley
,
M.
,
2017
, “
Peptides for Optical Medical Imaging and Steps Towards Therapy
,”
Bioorg. Med. Chem.
,
26
(10), pp. 2816–2826.
19.
Akram
,
A. R.
,
Avlonitis
,
N.
,
Lilienkampf
,
A.
,
Perez-Lopez
,
A. M.
,
Chankeshwara
,
S. V.
,
Scholefield
,
E.
,
Haslett
,
C.
,
Bradley
,
M.
, and
Dhaliwal
,
K.
,
2015
, “
A Labelled-Ubiquicidin Antimicrobial Peptide for Immediate in Situ Optical Detection of Live Bacteria in Human Alveolar Lung Tissue
,”
Chem. Sci.
,
6
(
12
), pp.
6971
6979
.
20.
Krstajić
,
N.
,
Akram
,
A. R.
,
Choudhary
,
T. R.
,
McDonald
,
N.
,
Tanner
,
M. G.
,
Pedretti
,
E.
,
Dalgarno
,
P. A.
,
Scholefield
,
E.
,
Girkin
,
J. M.
,
Moore
,
A.
,
Bradley
,
M.
, and
Dhaliwal
,
K.
,
2016
, “
Two-Color Widefield Fluorescence Microendoscopy Enables Multiplexed Molecular Imaging in the Alveolar Space of Human Lung Tissue
,”
J. Biomed. Opt.
,
21
(
4
), p.
046009
.
21.
ISO, 2007, “
Medical Devices—Application of Risk Management to Medical Devices
,” International Organization for Standardization, Geneva, Switzerland, Standard No.
ISO 14971:2007
.https://www.iso.org/standard/38193.html
22.
ISO, 1986, “
Conical Fittings With a 6% (Luer) Taper for Syringes, Needles and Certain Other Medical Equipment—Part 1: General Requirements
,” International Organization for Standardization, Geneva, Switzerland, Standard No.
ISO 594-1:1986
.https://www.iso.org/standard/4693.html
23.
ISO
, 2009, “
Biological Evaluation of Medical Devices—Part 1: Evaluation and Testing Within a Risk Management Process
,” International Organization for Standardization, Geneva, Switzerland, Standard No.
ISO 10993-1:2009
.https://www.iso.org/standard/44908.html
24.
FDA
,
2013
, “
Use of International Standard ISO 10993-1, ‘Biological Evaluation of Medical Devices—Part 1: Evaluation and Testing Within a Risk Management Process'
,” U.S. Food and Drug Administration, Silver Spring, MD.
25.
Arkema Group, 2018, “
Pebax Product Range and Properties
,” Arkema, Colombes, France, accessed Apr. 24, 2018, https://www.extremematerials-arkema.com/export/sites/technicalpolymers/.content/medias/downloads/brochures/pebax-brochures/pebax_product_range_and_properties.pdf
26.
Akram
,
A. R.
,
Avlonitis
,
N.
,
Craven
,
T.
,
Vendrell
,
M.
,
McDonald
,
N.
,
Scholefield
,
E.
,
Fisher
,
A.
,
Corris
,
P.
,
Haslett
,
C.
,
Bradley
,
M.
, and
Dhaliwal
,
K.
,
2016
, “
Structural Modifications of the Antimicrobial Peptide Ubiquicidin for Pulmonary Imaging of Bacteria in the Alveolar Space
,”
Lancet
,
387
, p.
S17
.
27.
Meeusen
,
E. N.
,
Snibson
,
K. J.
,
Hirst
,
S. J.
, and
Bischof
,
R. J.
,
2009
, “
Sheep as a Model Species for the Study and Treatment of Human Asthma and Other Respiratory Diseases
,”
Drug Discov. Today Dis. Models
,
6
(
4
), pp.
101
106
.
28.
ISO, 2008, “
Biological Evaluation of Medical Devices—Part 7: Ethylene Oxide Sterilization Residuals
,” International Organization for Standardization, Geneva, Switzerland, Standard No.
ISO 10993-7:2008
.https://www.iso.org/standard/34213.html
29.
Zenios
,
S. A.
,
Makower
,
J.
, and
Yock
,
P. G.
,
2015
,
Biodesign: The Process of Innovating Medical Technologies
, 2nd ed., Cambridge University Press, Cambridge, UK.
30.
FDA, 2015, “
Reprocessing of Reusable Medical Devices: Information for Manufacturers
,” U.S. Food and Drug Administration, Silver Spring, MD, accessed Feb. 6, 2018, https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ReprocessingofReusableMedicalDevices/default.htm
31.
e-CFR, 1996, “
Code of Federal Regulations
,” CFR Part 820—Quality System Regulation, Washington, DC, accessed Feb. 06, 2018, https://www.ecfr.gov/cgi-bin/text-idx?SID=f13f68b076448eb02b241cc6ebf0d7a0&mc=true&node=pt21.8.820&rgn=div5#se21.8.820_130
You do not currently have access to this content.